CPRXNEUTRAL

CPRX Revenue Growth (YoY) Analysis

5.6%

Higher than 32% of Healthcare sector peers

Updated 155h ago·SEC filings & market data

Key Takeaway

Revenue growth (YoY) measures how much a company’s sales increased compared to the same quarter one year earlier, expressed as a percentage.

Sector Performance

32th percentile

CPRX

5.6%

Sector Median

8.9%

Sector Avg

12.2%

📊

Deep Analysis

Revenue growth (YoY) measures how much a company’s sales increased compared to the same quarter one year earlier, expressed as a percentage.

CPRX’s current 5.6% growth falls below the healthcare sector median of 7.8%, placing it at the 35th percentile among peers, meaning most comparable companies grew faster. The trend is not assessable: both the year-over-year change and quarter-over-quarter change are N/A, and there is no data for the last eight quarters. With only a single data point and no trend, the level alone suggests modest but positive growth, which lowers immediate distress risk but offers little evidence of momentum. This inconclusive profile aligns with the overall NEUTRAL verdict, as the metric neither strengthens the case for buying nor raises urgent red flags. The 5.6% figure supports a wait-and-see stance rather than a strong bullish or bearish signal.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about CPRX?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does CPRX's Revenue Growth (YoY) compare to its sector?

CPRX's Revenue Growth (YoY) of 5.6% compares to a Healthcare sector median of 8.9%, placing it in the 32th percentile.

Who are CPRX's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: A (10.0%), ABT (7.8%), DGX (10.2%), RVTY (7.0%), CAH (11.0%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

Advertisement

Master CPRX's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full CPRX research report

Free account — no credit card

CPRX

5.6%

Sector Median

8.9%

Sector Avg

12.2%

How CPRX's Revenue Growth (YoY) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.